All Q4 FY26 results →
Y

Yasho Industries Ltd

Q4 FY26Chemicals & Petrochemicals

Yasho Industries Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹4,400
Market cap₹5.0K Cr
P/E95.9
Updated23 Aug 2026
Read4 min read

The short version

FY26 volume growth was 33% year-on-year. Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%.

From Yasho Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • FY26 volume growth was 33% year-on-year.
  • FY27 volume growth expected to be between 40% to 50%, driven by 15% increase in capacity utilization.
  • Capacity utilization targeted to ramp up to 75% by FY27.
  • FY28 revenue guidance is approximately INR 1,500 crores, including:
  • Capacity expansion done in FY26.
  • Commercialization of a long-term contract/project contributing to growth.
  • Volume growth primarily driven by the industrial segment; consumer segment may see slight dip.

2 more points from Yasho Industries Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Yasho Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D.
  • FY '27 planned capex: INR 125 crores, purely at Pakhajan; no capex contribution from the MNC project (separate).
  • Additional special project at Pakhajan with INR 90 crores capex ongoing.
  • Future capacity expansion at Pakhajan involves building additional production buildings (4 more possible).
  • Long-term contract signed in FY '26 with an advance of INR 51.4 crores; revenue expected from this starting FY '28.

2 more points from Yasho Industries Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Yasho Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The management did not explicitly mention a current or expected order book value during the call.
  • However, there is reference to commitments from customers based on gained confidence due to supply reliability, supporting the guidance of 70%-75% capacity utilization.
  • A strategic large project for an MNC is expected to start contributing commercially from early FY28, indicating some secured future orders.
  • About 40% of revenue in Q4 FY26 came from contracts with fixed pricing (quarterly or 6-monthly), and 60% from spot or regular customers, implying a mix of confirmed and variable orders.

2 more points from Yasho Industries Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Yasho Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹246 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

  • Rajputana Bio. (Q4 FY26)

    Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against

  • Neochem Bio (Q4 FY26)

    Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Yasho Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Yasho Industries Ltd Q4 FY26 results?

FY26 volume growth was 33% year-on-year. Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%.

What is Yasho Industries Ltd share price analysis?

Yasho Industries Ltd currently shows a neutral. The stock trades at a P/E of 95.8 with a market cap of ₹5,013 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yasho Industries Ltd planning capital expenditure?

FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D.

Keep Yasho Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.